Business Description
160 Health International Ltd
ISIN : KYG6S54B1005
Total Employee Number:
487Compare
Compare
Traded in other countries / regions
02656.Hong KongO66.Germany Index Membership
Hong Kong Stock Connect IPO Date
2025-09-17Description
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.6 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.05 | |||||
Debt-to-EBITDA | -3.88 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.53 | |||||
Beneish M-Score | -1.21 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.8 | |||||
3-Year EBITDA Growth Rate | -1.8 | |||||
3-Year EPS without NRI Growth Rate | 13.5 | |||||
3-Year FCF Growth Rate | -42.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.7 | |||||
9-Day RSI | 39.43 | |||||
14-Day RSI | 41.74 | |||||
3-1 Month Momentum % | -49.79 | |||||
6-1 Month Momentum % | -84.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 1.37 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 5.96 | |||||
Days Sales Outstanding | 100.74 | |||||
Days Payable | 79.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -14.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 26.12 | |||||
Operating Margin % | -9.74 | |||||
Net Margin % | -11.22 | |||||
EBITDA Margin % | -9.93 | |||||
FCF Margin % | -18.27 | |||||
OCF Margin % | -17.63 | |||||
ROE % | -344.24 | |||||
ROA % | -16.19 | |||||
ROIC % | -27.14 | |||||
3-Year ROIIC % | -18.92 | |||||
ROC (Joel Greenblatt) % | -222.46 | |||||
ROCE % | -259.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.27 | |||||
PB Ratio | 12.21 | |||||
Price-to-Tangible-Book | 12.37 | |||||
EV-to-EBIT | -43.3 | |||||
EV-to-EBITDA | -47.67 | |||||
EV-to-Revenue | 4.73 | |||||
EV-to-FCF | -25.91 | |||||
| Price-to-Net-Current-Asset-Value | 14.4 | |||||
Earnings Yield (Greenblatt) % | -2.31 | |||||
FCF Yield % | -3.91 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
160 Health International Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 716.744 | ||
| EPS (TTM) (HK$) | -0.264 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 41.74 | ||
| 14-Day ATR (HK$) | 0.871364 | ||
| 20-Day SMA (HK$) | 10.441 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 9.25 - 158.4 | ||
| Shares Outstanding (Mil) | 347.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
160 Health International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
160 Health International Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
160 Health International Ltd Frequently Asked Questions
What is 160 Health International Ltd(HKSE:02656)'s stock price today?
The current price of HKSE:02656 is HK$9.65. The 52 week high of HKSE:02656 is HK$158.40 and 52 week low is HK$9.25.
When is next earnings date of 160 Health International Ltd(HKSE:02656)?
The next earnings date of 160 Health International Ltd(HKSE:02656) is .
Does 160 Health International Ltd(HKSE:02656) pay dividends? If so, how much?
160 Health International Ltd(HKSE:02656) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on 160 Health International Ltd
No articles.